Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00539032Phase 3Completed
A Phase 3 trial of meningococcal A conjugate vaccine in invasive meningococcal disease (IMD), meningococcal meningitis, meningococcemia, sponsored by Sanofi. Started Sep 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00539032.